These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8029939)

  • 1. Use of anti-mu monoclonal antibody as a therapeutic approach to achieve depletion of xenoreactive natural antibodies.
    Soares M; Nisol F; Bach FH; Bazin H; Latinne D
    Transplant Proc; 1994 Jun; 26(3):1357-9. PubMed ID: 8029939
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo depletion of xenoreactive natural antibodies with an anti-mu monoclonal antibody.
    Soares MP; Latinne D; Elsen M; Figueroa J; Bach FH; Bazin H
    Transplantation; 1993 Dec; 56(6):1427-33. PubMed ID: 8279015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained suppression of xenoreactive natural antibodies: anti-IgM monoclonal antibody and anti-B cell immunosuppressants.
    Van der Werf WJ; Blakely ML; Hancock W; Soares M; Latinne D; Bazin H; Bach FH
    Transplant Proc; 1994 Jun; 26(3):1372-3. PubMed ID: 8029945
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-B cell agents: suppression of natural antibodies and prolongation of survival in discordant xenografts.
    Blakely ML; Van der Werf WJ; Dalmasso AP; Bach FH
    Transplant Proc; 1994 Jun; 26(3):1374-5. PubMed ID: 8029946
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterisation of rat anti-guinea pig circulating xenoreactive natural antibodies and secreting cells.
    Soares M; Havaux X; Van Beneden R; Van der Werf WJ; Bach FH; Bazin H; Latinne D
    Transplant Proc; 1995 Feb; 27(1):282-5. PubMed ID: 7879004
    [No Abstract]   [Full Text] [Related]  

  • 6. Removal of circulating IgM from xenograft recipients.
    Latinne D; Bazin H
    Transplant Proc; 1994 Jun; 26(3):1363-4. PubMed ID: 8029942
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts.
    Soares M; Lu X; Havaux X; Baranski A; Reding R; Latinne D; Daha M; Lambotte L; Bach FH; Bazin H
    Transplantation; 1994 Apr; 57(7):1003-9. PubMed ID: 8165695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful down-regulation of natural and xenoreactive antibodies in pig-to-baboon xenotransplantation by high-dose cyclophosphamide.
    Morschheuser T; Steinhoff G; Indzhiia L; Heiser A; Hein M; Lapin BA; Haverich A
    Transplant Proc; 1997; 29(1-2):970-2. PubMed ID: 9123612
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential inhibition of B-cell development and xenoreactive natural antibody production by administration of anti-mu or anti-delta monoclonal antibodies in adult rats.
    Soares M; Havaux X; Van Beneden R; Kinet I; Chentoufi AA; Nisol F; Cormont F; Bazin H; Latinne D
    Transplantation; 1998 Aug; 66(3):357-64. PubMed ID: 9721805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rejection of guinea pig cardiac xenografts post-cobra venom factor therapy is associated with infiltration by mononuclear cells secreting interferon-gamma and diffuse endothelial activation.
    Hancock WW; Blakely ML; Van der Werf W; Bach FH
    Transplant Proc; 1993 Oct; 25(5):2932. PubMed ID: 8212288
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of rat B cell differentiation in vivo by the administration of an anti-mu monoclonal antibody.
    Soares M; Havaux X; Nisol F; Bazin H; Latinne D
    J Immunol; 1996 Jan; 156(1):108-18. PubMed ID: 8598450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human naturally occurring antibodies to pig xenografts.
    Sandrin MS; Vaughan HA; Dabkowski PL; McKenzie IF
    Transplant Proc; 1994 Jun; 26(3):1392. PubMed ID: 7518133
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of B cells producing xenoreactive natural antibodies in humans.
    Goto M; Satake M; Sekiguchi S; Ohkohchi N; Satomi S
    Transplant Proc; 1999 Nov; 31(7):2707-8. PubMed ID: 10578259
    [No Abstract]   [Full Text] [Related]  

  • 14. Extracorporeal immunoadsorption of xenoreactive natural antibodies in the pig/rhesus model: comparison of three methods.
    Meyer C; Azimzadeh A; Beller JP; Kieny R; Lucchiari N; Ducros X; Boudjema K; Jaeck D; Cinqualbre J; Wolf P
    Transplant Proc; 1996 Apr; 28(2):799-800. PubMed ID: 8623406
    [No Abstract]   [Full Text] [Related]  

  • 15. Human xenoreactive natural antibodies--avidity and targets on porcine endothelial cells.
    Vanhove B; Bach FH
    Transplantation; 1993 Nov; 56(5):1251-3. PubMed ID: 8249132
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of bursectomy on deposition of natural xenoreactive antibodies and complement within rat cardiac xenografts in the chicken.
    Pruitt SK; Weinstock D; Suyemoto MM; Sanfilippo F; Baldwin WM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):435-7. PubMed ID: 8438367
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunochemical characterization of the binding of human immunoglobulins to pig vascular endothelium.
    Tuso PJ; Cramer DV; Yasunaga C; Cosenza C; Makowka L
    Transplant Proc; 1992 Apr; 24(2):596-7. PubMed ID: 1566445
    [No Abstract]   [Full Text] [Related]  

  • 18. Mizoribine inhibits natural antibody production in a discordant xenograft model.
    Flores HC; Leventhal JR; Gruber SA; Schaffer MM; Bolman RM; Matas AJ
    Transplant Proc; 1992 Apr; 24(2):717. PubMed ID: 1566497
    [No Abstract]   [Full Text] [Related]  

  • 19. Down-regulation of xenophile antibodies by 15-deoxyspergualin in an experimental animal model.
    Ulrichs K; Wang H; Müller-Ruchholtz W
    Transplant Proc; 1994 Apr; 26(2):994-6. PubMed ID: 8171724
    [No Abstract]   [Full Text] [Related]  

  • 20. Modification of rat xenoantibodies with guinea pig liver antigen and pulse cyclophosphamide.
    Goldberg LC; Buckland EJ; Taube D
    Transplant Proc; 1994 Jun; 26(3):1276-8. PubMed ID: 8029907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.